Publication | Closed Access

Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2

Bone Marrow FailureMedicineStem Cell MobilizationMolecular BiologyRankl ExpressionPharmacologyCell BiologyOsteoporosisNitrogen-containing BisphosphonateNovel Minodronic Acid